LLY

1,017.98

-0.58%↓

JNJ

198.99

+1.52%↑

ABBV

234.15

+0.77%↑

UNH

326.05

+1.46%↑

AZN

89.85

+0.8%↑

LLY

1,017.98

-0.58%↓

JNJ

198.99

+1.52%↑

ABBV

234.15

+0.77%↑

UNH

326.05

+1.46%↑

AZN

89.85

+0.8%↑

LLY

1,017.98

-0.58%↓

JNJ

198.99

+1.52%↑

ABBV

234.15

+0.77%↑

UNH

326.05

+1.46%↑

AZN

89.85

+0.8%↑

LLY

1,017.98

-0.58%↓

JNJ

198.99

+1.52%↑

ABBV

234.15

+0.77%↑

UNH

326.05

+1.46%↑

AZN

89.85

+0.8%↑

LLY

1,017.98

-0.58%↓

JNJ

198.99

+1.52%↑

ABBV

234.15

+0.77%↑

UNH

326.05

+1.46%↑

AZN

89.85

+0.8%↑

Начало・Списък с акции・Pulmatrix Inc

Pulmatrix Inc

Отворен

4.76 1.71

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

4.6

Максимум

4.74

Ключови измерители
By Trading Economics
Приходи	672K -877K
Марж на печалбата	-60,266.667
Служители	2
EBITDA	671K -877K

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-256K 18M
Предишно отваряне	3.05
Предишно затваряне	4.76

Pulmatrix Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.11.2025 г., 17:45 ч. UTC

Печалби

Значими двигатели на пазара

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

14.11.2025 г., 17:31 ч. UTC

Печалби

Значими двигатели на пазара

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

16.11.2025 г., 23:40 ч. UTC

Пазарно говорене

Gold Rises on Likely Technical Recovery -- Market Talk

16.11.2025 г., 23:36 ч. UTC

Пазарно говорене

Nikkei May Edge Lower Amid Lingering Worries Over Elevated Tech Valuations -- Market Talk

16.11.2025 г., 23:26 ч. UTC

Пазарно говорене

RBA Policy Meetings May Contain a Trap for Traders -- Market Talk

16.11.2025 г., 16:20 ч. UTC

Печалби

Fed Minutes, Plus Walmart, Target, Home Depot, Nvidia, and More Stocks to Watch This Week -- Barrons.com

15.11.2025 г., 09:20 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

15.11.2025 г., 09:20 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

15.11.2025 г., 00:08 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 3rd Update

14.11.2025 г., 23:56 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

14.11.2025 г., 23:02 ч. UTC

Пазарно говорене

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

14.11.2025 г., 22:35 ч. UTC

Печалби

Придобивния, сливания и поглъщания

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

14.11.2025 г., 22:32 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

14.11.2025 г., 22:29 ч. UTC

Печалби

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

14.11.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

14.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

14.11.2025 г., 21:18 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

14.11.2025 г., 20:27 ч. UTC

Пазарно говорене

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

14.11.2025 г., 20:23 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

14.11.2025 г., 20:17 ч. UTC

Придобивния, сливания и поглъщания

Several State Attorneys General Oppose Railroad Merger -- WSJ

14.11.2025 г., 19:29 ч. UTC

Пазарно говорене

Печалби

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

14.11.2025 г., 18:44 ч. UTC

Пазарно говорене

Печалби

Disney's Growth Now Hinges More on ESPN -- Market Talk

14.11.2025 г., 18:27 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

14.11.2025 г., 18:27 ч. UTC

Пазарно говорене

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

14.11.2025 г., 18:20 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

14.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Печалби

Auto & Transport Roundup: Market Talk

14.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

14.11.2025 г., 17:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

14.11.2025 г., 16:51 ч. UTC

Пазарно говорене

Starbucks Gets Holiday Sales Lift -- Market Talk

14.11.2025 г., 16:48 ч. UTC

Пазарно говорене

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Pulmatrix Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Pulmatrix Inc през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.